Acquisition of Aquila Biolabs GmbH (Details 1) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Earnings per share basic				$ (1.00)
Earnings per share Diluted				$ (1.00)
Revenues	$ 5,237,800	$ 5,758,600	$ 11,400,500	$ 9,775,200
Net loss	$ (4,079,400)	$ (2,105,300)	$ (13,668,100)	(3,672,500)
Pro forma information
Revenues				10,023,200
Net loss				$ (4,476,500)